Baxter forecast 2026 profit below estimates
Feb 12 (Reuters) - Medical products maker Baxter BAX.N forecast annual profit below Wall Street estimates on Thursday, due to persistent impact from hurricane-related disruptions at a key manufacturing unit. Baxter expects 2026 adjusted profit between $1.85 and $2.05 per share, well below analysts' average expectation of $2.25 per share, according to data compiled by LSEG. (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Baxter International
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Press Digest: British Business - August 20
Brief: Baxter Appoints John Rogers Chief Financial Officer
Brief: Baxter Announces Pricing For Its Upsized Cash Tender Offers